Osaic Holdings’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$145K Sell
114,924
-47
-0% -$59 ﹤0.01% 4415
2025
Q4
$140K Sell
114,971
-10,405
-8% -$15.6K ﹤0.01% 4430
2025
Q3
$186K Buy
125,376
+115,262
+1,140% +$176K ﹤0.01% 4284
2025
Q2
$11.8K Sell
10,114
-13,259
-57% -$18.7K ﹤0.01% 6050
2025
Q1
$31.6K Buy
23,373
+11,618
+99% +$70.5K ﹤0.01% 5036
2024
Q4
$155K Buy
+11,755
New +$160K ﹤0.01% 3826
2024
Q3
Sell
-360
Closed -$3.87K 7519
2024
Q2
$3.87K Buy
360
+33
+10% +$425 ﹤0.01% 6299
2024
Q1
$4.87K Sell
327
-1,904
-85% -$31.4K ﹤0.01% 6099
2023
Q4
$40.4K Sell
2,231
-3,911
-64% -$59.5K ﹤0.01% 5040
2023
Q3
$106K Buy
6,142
+3,396
+124% +$58.9K ﹤0.01% 4462
2023
Q2
$49.8K Buy
2,746
+1,331
+94% +$31.5K ﹤0.01% 4938
2023
Q1
$37.6K Buy
1,415
+878
+164% +$25K ﹤0.01% 5147
2022
Q4
$10.9K Buy
537
+403
+301% +$8.43K ﹤0.01% 5912
2022
Q3
$3K Buy
134
+100
+294% +$1.91K ﹤0.01% 6653
2022
Q2
$0 Hold
34
﹤0.01% 7533
2022
Q1
$0 Buy
34
+17
+100% +$173 ﹤0.01% 7427
2021
Q4
$0 Buy
+17
New +$270 ﹤0.01% 7523
2021
Q3
Sell
-150
Closed -$4K 7274
2021
Q2
$4K Sell
150
-150
-50% -$4.67K ﹤0.01% 6503
2021
Q1
$12K Sell
300
-650
-68% -$21.1K ﹤0.01% 5786
2020
Q4
$22K Sell
950
-225
-19% -$5.64K ﹤0.01% 5100
2020
Q3
$27K Sell
1,175
-625
-35% -$15.6K ﹤0.01% 4735
2020
Q2
$58K Buy
+1,800
New +$47.8K ﹤0.01% 4089

Other funds holding PLRX

Osaic Holdings's PLRX Position: Q1 2026 in Review

Osaic Holdings reduced its Pliant Therapeutics (PLRX) stake by 0.04% in Q1 2026, selling an estimated $59 and leaving 114,924 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #4415.

Osaic Holdings first reported a position in PLRX in Q2 2020 and has held it in 22 quarters since. The position peaked at $186K in Q3 2025. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Osaic Holdings held 114,924 shares of Pliant Therapeutics worth $145K as of Q1 2026.
  • Osaic Holdings sold 47 Pliant Therapeutics shares in Q1 2026, an estimated $59.
  • Pliant Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4415 holding.
  • Osaic Holdings first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 22 quarters since.
  • Osaic Holdings's Pliant Therapeutics position peaked at $186K in Q3 2025.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.